From L-R: Prevision Policy's Kate Rawson, OCE director Rick Pazdur, Hopkins professor Caleb Alexander, CBER deputy director Celia Witten, and OND Director Peter Stein (Zachary Brennan for Endpoints News)
Advisory committee votes aren't going away with incoming reforms, FDA officials say
WASHINGTON — Two top leaders from the FDA said changes to the agency’s advisory committee process won’t eliminate the up-or-down votes whose necessity Commissioner Rob Califf …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
